COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04512105
Recruitment Status : Recruiting
First Posted : August 13, 2020
Last Update Posted : December 4, 2020
United States Department of Defense
Information provided by (Responsible Party):
Elizabeth Brem, MD, University of California, Irvine

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 20, 2022
Estimated Study Completion Date : June 1, 2022